BioSpace News Archive

Daxor Corporation, an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measurement, announced that its CEO, Michael Feldschuh, will be a panelist in Maxim Group and M-Vest’s COVID-19 Virtual Series on May 27, 2020.

Alpine Immune Sciences, Inc., a leading clinical-stage immunotherapy company focused on developing innovative treatments for cancer and autoimmune/inflammatory diseases, announced its participation in an analyst-led fireside chat at the Jefferies Virtual Global Healthcare Conference on Tuesday, June 2, at 10:00 a.m. ET.

Atara Biotherapeutics, Inc. (Nasdaq:ATRA), a pioneer in T-cell immunotherapy leveraging its novel allogeneic EBV T-cell platform to develop transformative therapies for patients with severe diseases including solid tumors, hematologic cancers and autoimmune diseases, today announced that it has commenced an underwritten public offering of shares of its common stock and, to certain investors, pre-funded warrants to purchase shares of its common stock

Osmotica Pharmaceuticals plc (Nasdaq: OSMT) (“Osmotica” or the “Company”), a fully integrated biopharmaceutical company, announced today that Brian Markison, Chief Executive Officer, and Andrew Einhorn, Chief Financial Officer, will present at the 2020 Jefferies Virtual Healthcare Conference as follows

Spring Bank Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of viral infections, inflammatory diseases and certain cancers, announced that it will be participating in the Jefferies Virtual Global Healthcare Conference, taking place June 2-4, 2020.

Stealth BioTherapeutics Corp (Nasdaq: MITO), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases involving mitochondrial dysfunction, today announced that Reenie McCarthy, CEO, will participate in a fireside chat at the Jefferies Virtual Healthcare Conference on Tuesday, June 2 at 4:30 p.m. ET.

AnPac Bio-Medical Science Co., Ltd. announced that another new US patent titled “Apparatus for Improved Disease Detection” was granted to the Company by the United States Patent and Trademark Office on May 20, 2020, which is the second AnPac Bio patent granted this month, and the third in 2020.

United Imaging, a global leader in advanced medical imaging and radiotherapy equipment, announced U.S. Food & Drug Administration clearance of the uMR OMEGATM magnetic resonance imaging scanner.

Caladrius Biosciences, Inc. announced that it has entered into definitive agreements with several institutional and accredited investors for the issuance and sale of an aggregate of 2,084,850 shares of its common stock, at a purchase price of $2.0625 per share, in a registered direct offering priced at-the-market under Nasdaq rules.

Elevar Therapeutics, Inc., a late-stage biopharmaceutical company focused on developing and commercializing promising therapies to address unmet needs in cancer, announced that Mark Gelder, M.D. has been named vice president of medical affairs, effective immediately.